Is the new COVID-19 variant more dangerous?
England’s health secretary, Matt Hancock, has told parliament that a new variant of covid-19 has…
FDA
FDA approves another COVID-19 Vaccine.
FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second…
NEW VIDEO SERIES: Drugs Acting on CNS
Dear Reader Happy to share, I have started new video series on Drugs acting on…
FDA approves new dosing regimen for pembrolizumab
Food and Drug Administration granted accelerated approval to a new dosing regimen of 400 mg…
Convalescent Plasma: A Possible Treatment of COVID-19 in India
In India, SARS-CoV-2 virus-induced coronavirus disease 2019 (COVID-19) has already infected close to 31270 people,…
Conducting Clinical Trials During the COVID-19 Public Health Emergency
Reference: https://www.fda.gov/media/136238/download
FDA Reiterates Importance of Close Patient Supervision for ‘Off-Label’ Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
Today, the U.S. Food and Drug Administration issued a Drug Safety Communication regarding known side effects of…
Myths about Corona Virus.. Do you know this?
Here are few myths about corona virus which you should KNOW: Source: Google Images. Source:…
Covid-19: pandemic of 21st century.
Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. What is…
New Drug treatment for partial-onset seizures!
The U.S. Food and Drug Administration approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in…